A Study to Describe the Safety Profile and Compare the Immune Response of 4 Differents Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada
Condition: Tetanus Immunisation Diphtheria Immunisation Pertussis Immunisation (Healthy Volunteers) Interventions: Biological: Investigational Tdap vaccine Formulation B; Biological: Investigational Tdap vaccine Formulation C; Biological: Investigational Tdap vaccine Formulation A; Biological: Investigational Tdap vaccine Formulation D; Biological: Licensed Tdap vaccine Sponsor: Sanofi Pasteur, a Sanofi Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials